T-1201(taivex)

N/A

Report date: 2025/09/23 15:09:13
NME

Base Information

Drug NameT-1201(taivex)
Drug Alias NameBPRDP-056DBPR-186T-1201
ClassificationSmall molecules
Mechanisms of ActionApoptosis stimulantsMitosis inhibitorsTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesTaivex Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A